Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by 4Justiceon Sep 17, 2020 9:11am
91 Views
Post# 31573349

RE:RE:RE:RE:RE:RE:RE:H. C. Wainwright 22nd Annual Global Investment Conference

RE:RE:RE:RE:RE:RE:RE:H. C. Wainwright 22nd Annual Global Investment Conference Yes, they know very well the company. That,s why Thomvest fired Clulow from the board but also from the investment company. They reduced the crdit margin to Liminal from $75 millions to $ 29 millions fdollowing the sale of prometic Bio-Sciences. They burned this money. Today the are starting tu use this last tiny credit margin. Be sure that Thomvest won't put more money in this story.

It's an evidence and you're close to your last pay check my friend. Sorry
<< Previous
Bullboard Posts
Next >>